Laparoscopy for the Confirmation and Prognostic Evaluation of Pelvic Inflammatory Disease

Chaparro, Mario V.; Ghosh, Snehanshu; Nashed, Adel W.; Poliak, Aaron

doi:10.1002/j.1879-3479.1977.tb00699.x

Cited by 45 publications

(7 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…We found a high frequency of postabortal PID. This might be due to the relatively low sensitivity of the clinical diagnosis of acute PID (Jacobsen Westrøm 1969; Chaparro et al . 1978), the long postabortal follow‐up and the involvement of many different general practitioners.…”

Section: Discussionmentioning

confidence: 99%

A double‐blind randomized study of the effect of erythromycin in preventing pelvic inflammatory disease after first trimester abortion

Sørensen¹,

Thranov²,

Hoff³

et al. 1992

BJOG

View full text Add to dashboard Cite

Objective To assess the prophylactic use of erythromycin in prevention of post‐abortal pelvic inflammation disease (PID) in first trimester abortion. Design Double‐blind, randomized controlled trial. Setting Department of Surgery, County Hospital, Denmark. Subjects Four hundred and thirty two women who were to undergo induced abortion before 12 weeks gestation were randomized to be treated either with prophylactic erythromycin or a placebo. Intervention The women were randomized to receive a placebo or erythromycin, 500 mg twice a day for 71/2 days starting the evening before the abortion. All the women were investigated for Chlamydia trachomatis and Neisseria gonorrhoea before the abortion. Main outcome measures Frequency of cervical C. trachomatis and N. gonorrhoea and frequency of PID after abortion. Results Fifty four women were excluded after randomization. The frequency of PID was 11% (20/189) in the erythromycin group and 16% (30/189) in the placebo group (P= 0.13, χ2‐test). The prevalence of C. trachomatis was 19% (15/78) in women ≤ 20 years of age, 13% (14/109) in women between 21 and 25 years and 2% (5/241) in women ≤ 26 years of age. In women positive for C. trachomatis erythromycin prophylaxis significantly reduced the frequency of PID to 8% (l/13) compared with 43% (6/14) in the placebo group (P= 0.051, logistic regression analysis). Erythromycin had no effect on other potential high risk groups (first pregnancy, nulliparous, <20 years of age, and women with previous PID). Conclusion Prophylactic erythromycin is not warranted for all women having an abortion. Cervical C. trachomatis is a risk factor for postabortal PID, and prophylaxis with erythromycin significantly reduces the frequency of PID. However, only a few women with PID had cervical C. trachomatis, and the prevention of post‐abortal PID remains a major challenge requiring further studies.

show abstract

Section: Discussionmentioning

confidence: 99%

A double‐blind randomized study of the effect of erythromycin in preventing pelvic inflammatory disease after first trimester abortion

Sørensen¹,

Thranov²,

Hoff³

et al. 1992

BJOG

View full text Add to dashboard Cite

show abstract

“…Among women with initial clinical diagnosis of acute PID, PID was confirmed at subsequent surgery (either laparoscopy or laparotomy) in 38-70% of the cases [24][25][26][27][28]. In the present study, among 17 women with complaints of pelvic pain and in whom adnexal masses were palpated and ultrasonographic findings were abnormal, PID was diagnosed in only three (17.7%).…”

Section: Discussionmentioning

confidence: 47%

Clinical experience with intrauterine devices in a private practice

1985

Adv Contracept

View full text Add to dashboard Cite

Clinical experience with intrauterine devices was evaluated, based on 627 insertions over a 14-year period in a private practice. Overall, there were few differences in the event rates leading to IUD discontinuation for the IUDs evaluated, principally Cu-7, Dalkon Shield and Lippes Loop. Pelvic infections were infrequent (0.7-2.2 cases per 100 woman-years of IUD use). The rate of PID in the study population appeared to be similar to that noted in the general population. IUD use did not appear to compromise future fertility, based on evaluations of patients after removal of their IUDs or from their return to fertility following IUD removal. IUD event rates (pregnancy, expulsion, displacement, removal for bleeding and/or pain) were related to the difference between endometrial cavity length and IUD length. A significant increase in the event rates was noted, regardless of the IUD type, when the endometrial cavity length exceeded IUD length by 2.0 cm or more, or when the difference between the endometrial cavity and IUD length was less than 0.5 cm.

show abstract

“…Laparoscopy has proved valuable in confirming presumptive PID, yet it is inconsistently and infrequently used because of its availability and cost. Chapparo, Ghosh, Nashed, and Poliak (1978) documented laparoscopic evidence of salpingitis in 46% of women not clinically thought to have PID. Conversely, many women admitted to the hospital with PID have normal findings on laparoscopic examination (Lipscomb & Ling, 1993).…”

Section: Accurate Diagnosis Of Pid Is Confounded By a Variety Of Gynementioning

confidence: 99%

Pelvic Inflammatory Disease: Clinical Overview

Kottmann

1995

Journal of Obstetric, Gynecologic & Neonatal Nursing

View full text Add to dashboard Cite

Laparoscopy for the Confirmation and Prognostic Evaluation of Pelvic Inflammatory Disease

Cited by 45 publications

References 4 publications

A double‐blind randomized study of the effect of erythromycin in preventing pelvic inflammatory disease after first trimester abortion

A double‐blind randomized study of the effect of erythromycin in preventing pelvic inflammatory disease after first trimester abortion

Clinical experience with intrauterine devices in a private practice

Pelvic Inflammatory Disease: Clinical Overview

Contact Info

Product

Resources

About